Skip to content

Advanced Hemodynamic Monitoring for Goal-directed Hemodynamic Management During Radical Cystectomy

Advanced Hemodynamic Monitoring for Goal-directed Hemodynamic Management During Radical Cystectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00966147
Enrollment
Unknown
Registered
2009-08-26
Start date
2009-10-31
Completion date
Unknown
Last updated
2009-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamic Monitoring, Perioperative Complications, Radical Cystectomy

Brief summary

The purpose of this study is to determine whether increasing cardiac output by a combination of intravenous fluids and inotropic drugs can reduce mortality and morbidity in radical cystectomy operations.

Interventions

OTHERIncreasing oxygen delivery .

The target is increasing oxygen delivery above 600ml/min/mr2 by either bolus of iv colloid or a continuous infusion of dopamine, dobutamine or noradrenaline. The fluids and drug administration will be directed and monitored by the lidco system and transesophageal echocardiography.

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (\>18yo) scheduled for elective radical cystectomy and ileal conduit formation

Exclusion criteria

* Creatinine level above 200 mcg/dl * single functioning kidney * s/p kidney transplant * heart rhythm other than sinus * known allergy to lithium chloride * chronic lithium therapy * weight below 40 kg * mental or language problems that precludes obtaining informed consent

Design outcomes

Primary

MeasureTime frame
MortalityHospital stay

Secondary

MeasureTime frame
MorbidityHospital stay

Countries

Israel

Contacts

Primary ContactYuval Meroz, MD
merozy@hadassah.org.il97226777719

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026